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Pulmonary-renalsyndromeisamedicalemergency;etiologyofwhichhasbroaddiﬀerentialdiagnosis.Delayinbothdiagnosisand
initiation of management may result in end-organ damage. Management decisions may have to be empiric till a rapid, deﬁnitive
tissue diagnosis is established. We present such a case where prompt recognition and immediate treatment was initiated, although
the patient sustainedirreversible end-organ damage.The case alsohighlightsthe need to interpret the kidney biopsydata (namely,
immunoﬂuroscenceﬁndings) in the context of clinical presentation.
1.CasePresentation
A 26-year-old male presented to our hospital complaining of
cough and hemoptysis for 7 days. A resident of Columbia,
Mo, he had recently ﬂown back home from vacation in
California. He denied chest pain or fever. There was no
signiﬁcant past medical history, and the patient was not
on any medications. He smoked 1-2 cigarettes per day, but
denied alcohol intake or drug abuse. Family history was
signiﬁcant for hypertension in both parents.
Onarrivaltothehospital,thepatient’spulsewas112/min
and regular, and BP was 220/128mmHg, respiratory rate
38/min. He was hypoxic, saturating 88% on room air. The
patient appeared ill and pale. Respiratory exam revealed
bilateral coarse crackles. Neurological exam was normal.
Bilateral optic disc margins were blurred, and retinal
exudates and hemorrhages were noted. No skin rash was
present. Patient was intubated for hypoxic respiratory failure
and started on intravenous labetalol. Bronchoscopy revealed
active lung hemorrhage (LH). Laboratory data showed
anemia, thrombocytopenia, and renal failure (Table 1).
Presuming thediagnosisofapulmonary renalsyndrome,
the patient was treated with 1-gram methylprednisolone and
plasmapheresis pending results of serological investigations.
Hemodialysis was initiated for anuric renal failure. A left
renal biopsy was performed. A total of 17 glomeruli were
obtained. Changes secondary to malignant hypertension,
(Figures 1(a) and 1(b)) and superimposed changes sec-
ondary to chronic hypertension (Figures 2(a) and 2(b)) were
noted. Immunoﬂuorescence showed peripheral C3 trapping
and weak (1+) linear staining of glomerular basement
membrane by IgG. After renal biopsy, patient had an episode
of bleeding for which he underwent left renal arteriolar
embolization.
A diagnosis of malignant hypertension (MHT) present-
ing with LH, with acute anuric renal failure from thrombotic
microangiopathyandwithunderlyingchronickidneydisease
secondarytoprimaryhypertension wasmade.Onlyfewcases
of malignant hypertension presenting as pulmonary renal
syndrome have been reported [1–3].
2.Discussion
Patient’s strong family history, negative past medical history,
and relatively small kidneys with increased echogenicity
on ultrasound suggest that our patient most likely had
underlying CKD secondary to uncontrolled severe primary
hypertension. The selective angiogram performed for post-
biopsycomplicationdidnotrevealrenalartery stenosisofthe
left (smaller) kidney. A hypothesis that extreme BP elevation2 International Journal of Hypertension
Table 1: Laboratory data.
CBC Hb WBC Platelets PT aPTT
8.5g/dL 5.1 ×103 mcL 94 ×103 mcL 17.7sec 35.3sec
BMP Na K Cl HCO3 BUN Creatinine
141mmol/L 4.1mmol/L 104mmol/L 14mmol/L 108mg/dL 13.34mg/dL
UA Large blood 6–10rbc/hpf >300mg/dL No casts Myoglobulin negative
Serology p-ANCA c-ANCA Anti MPO Anti PR3 SSA/SSB/SCL-70 ANA/anti-ds DNA Anti-GBM
Neg Neg Neg Neg Neg Neg Neg
Miscellaneous Inﬂuenza Blood culture Sputum cultures
A/B Neg Neg Neg
Chest Xray Bilateral pulmonary inﬁltrates. No cavitory lesions noted.
CT Chest No pulmonary embolism.
Ultrasound Increased bilateral echogenicity. Rt kidney 10cm, Lt kidney 9.0cm.
Echocardiogram Left ventricular hypertrophy.
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Figure 1: (a) Glomerular ﬁbrinoid necrosis (∗)a n dac r e s c e n t
(∗∗). (b) Arteriole with ﬁbrinoid necrosis (∧) with luminal
narrowing.
leads to vascular endothelial damage or hormonal changes
(namely renin-angiotensin-aldosterone system activation)
m a ye x p l a i nw h ys o m ep e o p l ep r o g r e s st oM H Tp h a s e[ 4].
In MHT, narrowed arteriolar lumen (due to myointimal
hyperplasia and ﬁbrinoid necrosis) and endothelial damage
leading to thrombotic lesions in the arterioles result in shear
stress on passing blood stream. The mechanical destruction
of red blood cells leads to microangiopathic hemolytic
anemia. Clinical diﬀerentiation between TTP and malignant
hypertension can be diﬃcult, but normal mental status and
normal ADAMTS-13 helped rule out TTP in our case.
The mechanism of pulmonary hemorrhage remains
unclear in our case. Smoking, platelet dysfunction due to
underlying uremia, and thrombocytopenia due to MAHA
may have predisposed our patient to pulmonary hemor-
rhage. Pulmonary hemorrhage during air travel has been
⋆
♦
(a)
(b)
∧
Figure 2:Changes due to chronic hypertension. (a) Periglomerular
ﬁbrosis (
￿),thickcapillary walls(∧).(b) Arteriole withmyointimal
hyperplasia (
￿).
reported, but those patients had underlying chronic lung
conditions [5], which were not found in our patient.
In absence of serum antibodies to the GBM, we inter-
preted the low-intensity linear IgG staining of the GBM as
false positive. Biopsies from patients with diabetic glomeru-
losclerosis, hypertensive vascular disease, renal transplant,
myeloma, SLE, deceased donor kidneys after perfusion, and
normal autopsy kidneys may have less intense linear IgG
deposits.
Our patient remains dialysis dependant and is currently
on the transplant list. Serum creatinine at presentation
remains a signiﬁcant prognostic factor for renal recovery in
patients with malignant hypertension [6].
Physicians should be aware of MHT as a presentation of
pulmonary-renal syndrome.
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